1 interaction related to foundayo
Orforglipron (Foundayo) is broken down mainly by the liver enzyme CYP3A4. Its label says to avoid strong CYP3A4 inducers because they lower orforglipron levels and may make it work less well; in a study, the strong inducer carbamazepine cut orforglipron exposure by 82%. The FDA classes St. John's wort as a strong CYP3A inducer, although its effect varies by product. No study has tested St. John's wort with orforglipron, so the size of the drop is predicted from the class, not measured.